ACUMEN PHARMACEUTICALS INC. - COMMON STOCK
1.7700
24-12月-24 12:36:44
15 分の遅延
株式
0.0000
0.00%
本日の幅
1.7300 - 1.8300
ISIN
N/A
ソース
NASDAQ
-
Acumen Pharmaceuticals to Participate in the Cantor Global Healthcare Conference
19 9 2023 16:00:00 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Participate in the H.C. Wainwright Annual Global Investment Conference
06 9 2023 16:00:00 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business Highlights
08 8 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 8, 2023
01 8 2023 16:00:00 提供 Nasdaq GlobeNewswire
-
Acumen Announces Pricing of Upsized $130 Million Public Offering
18 7 2023 22:31:16 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Announces Proposed Public Offering of Common Stock
17 7 2023 16:53:41 提供 Nasdaq GlobeNewswire
-
17 7 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Highlights
09 5 2023 07:00:03 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Participate in 2023 Bank of America Healthcare Conference
04 5 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Report First Quarter Financial Results on May 9, 2023
02 5 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
28 3 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
27 3 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Participate in Stifel 2023 Virtual CNS Days
22 3 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
20 3 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Participate in the Needham Neuroscience Forum
08 3 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Appoints Derrell Porter, M.D., to its Board of Directors
04 1 2023 08:00:02 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Highlights
14 11 2022 16:01:01 提供 Nasdaq GlobeNewswire